- Home
- WULF vs RCKT Comparison
WULF vs RCKT Comparison
Compare WULF & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WULF | RCKT |
|---|---|---|
| Founded | 1952 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 340.9M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | WULF | RCKT |
|---|---|---|
| Price | $11.75 | $3.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $17.04 | ★ $29.12 |
| AVG Volume (30 Days) | ★ 28.9M | 1.9M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $167,604,000.00 | N/A |
| Revenue This Year | $30.84 | N/A |
| Revenue Next Year | $123.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.58 | N/A |
| 52 Week Low | $2.06 | $2.19 |
| 52 Week High | $17.05 | $13.35 |
Technical Indicators
Market Signals| Indicator | WULF | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 55.01 |
| Support Level | $11.32 | $3.19 |
| Resistance Level | $13.64 | $3.60 |
| Average True Range (ATR) | 1.18 | 0.19 |
| MACD | -0.27 | 0.02 |
| Stochastic Oscillator | 8.56 | 70.65 |
Price Performance
Historical ComparisonAbout WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.